Liu J - Search Results

1

A favorable inductive remission rate for decitabine combined with chemotherapy as a first course in <60-year-old acute myeloid leukemia patients with myelodysplasia syndrome features.

Liu F, Wang H, Liu J, Zhou Z, Zheng D, Huang B, Su C, Zou W, Xu D, Tong X, Li J. Liu F, et al. Among authors: liu j. Cancer Med. 2019 Sep;8(11):5108-5115. doi: 10.1002/cam4.2418. Epub 2019 Jul 19. Cancer Med. 2019. PMID: 31322840 Free PMC article.

2

[Expression and clinical significance of vascular endothelial growth factor and its receptors in multiple myeloma].

Liu JR, Luo SK, Li J, Su C. Liu JR, et al. Ai Zheng. 2007 Jun;26(6):652-6. Ai Zheng. 2007. PMID: 17562275 Free article. Chinese.

3

Expression of soluble Flt-1 gene in Pichia pastoris and the effect of the product on multiple-myeloma cells in vitro.

Liu J, Li J, Su C, Huang B, Luo S. Liu J, et al. Biotechnol Appl Biochem. 2008 Feb;49(Pt 2):97-104. doi: 10.1042/BA20070053. Biotechnol Appl Biochem. 2008. PMID: 17614789

4

Soluble Fms-like tyrosine kinase-1 expression inhibits the growth of multiple myeloma in nude mice.

Liu J, Li J, Su C, Huang B, Luo S. Liu J, et al. Acta Biochim Biophys Sin (Shanghai). 2007 Jul;39(7):499-506. doi: 10.1111/j.1745-7270.2007.00310.x. Acta Biochim Biophys Sin (Shanghai). 2007. PMID: 17622469 Free article.

5

[In vitro study of human multiple myeloma cell transfected with soluble vascular endothelial growth factor receptor-1 gene].

Zheng D, Li J, Liu JR, Zhou ZH, Gu JL. Zheng D, et al. Among authors: liu jr. Chin J Cancer. 2010 Jan;29(1):65-8. Chin J Cancer. 2010. PMID: 20038313 Free article. Chinese.

6

[The clinical features and risk factors for invasive fungal infection in multiple myeloma.].

Huang BH, Li J, Liu JR, Gu JL. Huang BH, et al. Among authors: liu jr. Zhonghua Nei Ke Za Zhi. 2009 Dec;48(12):1026-30. Zhonghua Nei Ke Za Zhi. 2009. PMID: 20193522 Chinese.

7

High prevalence of hepatitis B virus infection in multiple myeloma.

Huang B, Li J, Zhou Z, Zheng D, Liu J, Chen M. Huang B, et al. Among authors: liu j. Leuk Lymphoma. 2012 Feb;53(2):270-4. doi: 10.3109/10428194.2011.610013. Epub 2011 Oct 24. Leuk Lymphoma. 2012. PMID: 21823833

8

[Maintenance therapies of thalidomine and interferon-α in multiple myeloma].

Li J, Cai JH, Huang BH, Liu JR, Zheng D. Li J, et al. Among authors: liu jr. Zhonghua Yi Xue Za Zhi. 2011 Dec 27;91(48):3417-20. Zhonghua Yi Xue Za Zhi. 2011. PMID: 22333255 Chinese.

9

Differentiation induction enhances bortezomib efficacy and overcomes drug resistance in multiple myeloma.

Gu JL, Li J, Zhou ZH, Liu JR, Huang BH, Zheng D, Su C. Gu JL, et al. Among authors: liu jr. Biochem Biophys Res Commun. 2012 Apr 13;420(3):644-50. doi: 10.1016/j.bbrc.2012.03.056. Epub 2012 Mar 17. Biochem Biophys Res Commun. 2012. PMID: 22450313

10

[The efficacy and safety of bortezomib-based induction regimen before autologous hematopoietic stem cell transplantation in patients with multiple myeloma].

Li J, Liu JR, Huang BH, Chen M, Zheng D, Xu DR, Zou WY. Li J, et al. Among authors: liu jr. Zhonghua Nei Ke Za Zhi. 2012 Apr;51(4):279-83. Zhonghua Nei Ke Za Zhi. 2012. PMID: 22781947 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

146,894 results

Search Page

Filters